Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05740176 · ClinicalTrials.gov registry record · NA
The Synergy Disc for the Treatment of 2 Level Cervical Degenerative Disc Disease Compared With Cervical Fusion Surgery
A NA study of Cervical Degenerative Disc Disease, sponsored by Synergy Spine Solutions.
- Active
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 20
- Study locations
NCT05740176: Active NA study of Cervical Degenerative Disc Disease, sponsored by Synergy Spine Solutions.
NCT05740176 is a NA study of Cervical Degenerative Disc Disease that is active but no longer recruiting, run by Synergy Spine Solutions. The registered enrollment target is 200 participants, below the 244-participant average among 4 other Cervical Degenerative Disc Disease trials with a reported enrollment target (18% lower). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05740176, a NA study of Cervical Degenerative Disc Disease, is active but no longer recruiting, sponsored by Synergy Spine Solutions.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 20
- Study locations
Study Summary
A multicenter, prospective, non-randomized, historically controlled study. To demonstrate the Synergy Disc is at least as safe and effective as conventional anterior cervical discectomy and fusion (ACDF) to treat cervical degenerative disc disease (DDD) in subjects who are symptomatic at two levels from C3 to C7 are and are unresponsive to conservative management. Patients will be evaluated preoperatively, at the time of surgery, and at 6 weeks, and 3, 6, 12, and 24 months after surgery. Follow-up will continue annually until the last patient reaches 24-month follow-up. The primary analysis will occur at 24 months.
Primary Outcome
≥ 15-point improvement in NDI Score (out of 100) in subjects at 24 months compared with baseline
Conditions Studied
Interventions
- DEVICE Anterior Cervical Discectomy and Fusion
Study Locations (20)
California
- Todd Lanman, MD - Beverly Hills
- DOCS Health Management LLC - Los Angeles
- Institute of Neuro Innovation - Santa Monica
North Carolina
- Carolina NeuroSurgery and Spine Associates, PA - Charlotte
- M3 Emerging Medical Research - Durham
- Pinehurst Surgical Clinic - Pinehurst
Florida
- Brain and Spine Center of South Florida - Delray Beach
- Kennedy-White Orthopaedic Center - Sarasota
Indiana
- Indiana Spine Group - Carmel
- Orthopedics Northeast - Fort Wayne
Louisiana
- Bone and Joint Clinic of Baton Rouge - Baton Rouge
- Louisiana Spine Institute - Shreveport
Oregon
- Summit Spine - Portland
- Oregon Spine Care - Tualatin
Texas
- Austin Neurosurgeons - Austin
- DFW Center for Spinal Disorders - Fort Worth
Arizona
- HonorHealth - Scottsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2026-12 |
| Phase | NA |
What the registry record for NCT05740176 still lists
NCT05740176 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 244-participant average among 4 other Cervical Degenerative Disc Disease trials with a reported enrollment target (18% lower).
The record links to 1 condition, with Cervical Degenerative Disc Disease appearing as the primary indexed condition, and to 1 intervention - of which Anterior Cervical Discectomy and Fusion is the first listed.
NCT05740176 names 20 study sites across 11 states, led by California, North Carolina, Florida.
Frequently Asked Questions
What is clinical trial NCT05740176 about?
NCT05740176 is a clinical study titled "The Synergy Disc for the Treatment of 2 Level Cervical Degenerative Disc Disease Compared With Cervical Fusion Surgery". A multicenter, prospective, non-randomized, historically controlled study. To demonstrate the Synergy Disc is at least as safe and effective as conventional anterior cervical discectomy and fusion (ACDF) to treat cervical degenerative disc disease (DDD) in subjects who are symptomatic at two levels ...
What is the current status of trial NCT05740176?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-06-01. Estimated completion is 2026-12.
What conditions does trial NCT05740176 study?
This clinical trial studies the following conditions: Cervical Degenerative Disc Disease.
What interventions are being tested in trial NCT05740176?
The interventions under investigation include: Anterior Cervical Discectomy and Fusion (DEVICE).
Who is sponsoring clinical trial NCT05740176?
This trial is sponsored by Synergy Spine Solutions, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05740176 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Florida, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Degenerative Disc Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Synergy Disc To Anterior Cervical Discectomy and Fusion
ACTIVE NOT RECRUITING · NA
-
Comparison of DISCOVER™ Artificial Cervical Disc and ACDF for Treatment of Cervical DDD (IDE Study)
COMPLETED · NA
-
Investigation of the Simplify® Cervical Artificial Disc
COMPLETED · NA
-
M6-C Post Approval Study (PAS)
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI